HYUNDAI BIOLAND Co.,Ltd. (KOSDAQ:052260)

Market Cap	120.75B -14.5%
Revenue (ttm)	129.68B +16.0%
Net Income	-3.14B
EPS	-104.67
Shares Out	30.00M
PE Ratio	9.70
Forward PE	n/a
Dividend	35.00 (0.84%)
Ex-Dividend Date	Apr 2, 2026

Volume	76,693
Average Volume	124,016
Open	4,065.00
Previous Close	4,175.00
Day's Range	4,040.00 - 4,200.00
52-Week Range	3,825.00 - 5,420.00
Beta	0.84
RSI	37.49
Earnings Date	Mar 11, 2026

About HYUNDAI BIOLAND

HYUNDAI BIOLAND Co.,Ltd., together with its subsidiaries, manufactures and sells cosmetic raw materials, health food raw materials, medical devices, and pharmaceutical raw materials worldwide. The company offers cosmetics, such as whitening, skin protection, moisturizing, anti-aging, sheet mask, and hair and body care products, as well as general/health functional food ingredients. It is also involved in the provision of medical biomaterials for dental, wound, orthopedic, and biomaterial applications; and manufacture and supplying of active pha...

• Industry: Pharmaceutical Preparations
• Founded: 1995
• Employees: 341
• Stock Exchange: KOSDAQ
• Ticker Symbol: 052260

Financial Performance

In 2024, HYUNDAI BIOLAND's revenue was 119.52 billion, an increase of 23.57% compared to the previous year's 96.72 billion. Earnings were 5.70 billion, a decrease of -29.21%.